Utah Medical Products, Inc.

NASDAQ:UTMD

67.91 (USD) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996199519941993199219911990198919881987
Revenue 50.22452.28149.05442.17846.90441.99841.41439.29840.15741.27840.49341.55237.8625.12125.91627.78228.50228.75327.69226.48527.13727.36126.95427.19329.44427.724.338.74239.63736.129.823.917.913.57.6
Cost of Revenue 25.87820.08518.13716.6317.43815.69215.01915.60815.97216.29516.22116.24515.4611.91112.12712.76412.71412.60611.93911.41911.24511.59811.56112.06811.45611.410.218.120.820.719.519.316.91410.58.44.8
Gross Profit 24.34632.19630.91725.54829.46626.30626.39523.6924.18524.98324.27225.30722.413.2113.78915.01815.78816.14715.75315.06615.89215.76315.39315.12517.98816.314.120.621.218.917.516.812.99.97.45.12.8
Gross Profit Ratio 0.4850.6160.630.6060.6280.6260.6370.6030.6020.6050.5990.6090.5920.5260.5320.5410.5540.5620.5690.5690.5860.5760.5710.5560.6110.5880.580.5320.5050.4770.4730.4650.4330.4140.4130.3780.368
Reseach & Development Expenses 0.560.4930.5260.4860.4830.4540.4470.4750.5220.460.4910.5630.5180.3970.3610.3590.3820.3160.320.2920.2880.2850.3640.5680.7190.911.41.81.50000000
General & Administrative Expenses 11.01610.40610.0979.89.6135.4475.3935.3555.8486.116.1646.8367.2252.3542.4120000000000000000000000
Selling & Marketing Expenses 1.6851.5071.4141.5541.7381.7081.5441.6732.1642.2112.792.7112.8151.5371.5840000000000000000000000
SG&A 5.34911.91311.51111.35411.3517.1556.9377.0288.0128.3218.9549.54710.043.8913.9964.274.654.9976.1954.6654.8824.9365.7516.196.7956.66.15.966.17.66.54.33.432.51.7
Other Expenses 0.2760.2080.0150.02-0.0020.5130.0540.223-0.046-0.1080.079-0.01700000-0.0010.001000002.1922.11.51.41.71.310.90.60.50.50.60.4
Operating Expenses 5.90912.40612.03711.8411.8347.6097.3847.5038.5348.7819.44510.1110.5584.2884.3574.6295.0325.3126.5164.9575.175.2216.1156.7589.7069.68.68.79.58.98.67.44.93.93.53.12.1
Operating Income 18.43712.70818.886.49910.75118.69719.01116.18715.65116.20214.82815.19611.8428.9229.43210.38910.75610.8359.23710.10910.72210.5429.2788.3678.2826.75.511.911.7108.99.4863.920.7
Operating Income Ratio 0.3670.2430.3850.1540.2290.4450.4590.4120.390.3930.3660.3660.3130.3550.3640.3740.3770.3770.3340.3820.3950.3850.3440.3080.2810.2420.2260.3070.2790.2530.2410.260.2680.2510.2180.1480.092
Total Other Income Expenses Net 1.6527.9510.1817.3417.1330.7620.0710.235-0.041-0.1010.086-0.0070.0820.095-0.0080.0430.550.9750.5890.560.4960.4840.5630.510.5251.21.51.81.20.91.71.10.40.80.30.20
Income Before Tax 20.08920.65919.06113.8417.88419.45819.08216.42215.54515.81214.47614.53711.089.0419.5810.77712.03812.41810.21410.90711.17610.9969.488.428.5457.66.813.712.910.910.610.68.36.74.120.7
Income Before Tax Ratio 0.40.3950.3890.3280.3810.4630.4610.4180.3870.3830.3570.350.2930.360.370.3880.4220.4320.3690.4120.4120.4020.3520.310.290.2740.280.3540.3070.2750.2860.2940.2790.280.2290.1480.092
Income Tax Expense 3.4544.1864.2733.0423.1570.90410.5774.2943.7024.4343.074.3683.6663.0263.3223.5724.1344.252.6673.7413.8413.8313.5463.0473.0772.72.54.94.53.83.63.72.92.41.50.60.3
Net Income 16.63516.47314.78810.79814.72718.5548.50512.12811.84311.37811.40610.1697.4146.0146.2587.2057.9058.1687.54710.2220.7617.1655.9345.3735.4684.94.38.88.47.176.95.44.32.61.40.4
Net Income Ratio 0.3310.3150.3010.2560.3140.4420.2050.3090.2950.2760.2820.2450.1960.2390.2410.2590.2770.2840.2730.3860.7650.2620.220.1980.1860.1770.1770.2270.20.1790.1890.1910.1810.180.1450.1040.053
EPS 4.584.534.052.953.964.972.293.223.143.023.022.742.041.661.731.872.012.071.912.324.591.461.180.90.760.590.510.940.830.680.60.580.460.370.230.130.04
EPS Diluted 4.574.524.042.943.944.952.283.223.143.013.022.742.031.651.721.861.982.021.82.194.251.361.140.90.760.590.510.930.820.680.60.570.460.370.230.130.04
EBITDA 24.80519.7930.91713.70817.633-18.69721.83823.6924.18524.98314.82815.17911.84225.12125.91610.93710.80310.4949.32410.35811.2111.2310.64810.0489.9497.65.511.512.210.48.29.28.25.74.12.41.1
EBITDA Ratio 0.4940.3790.630.3250.376-0.4450.5270.6030.6020.6050.3660.3650.313110.3940.3790.3650.3370.3910.4130.410.3950.370.3380.2740.2260.2970.290.2630.2220.2550.2750.2380.2290.1780.145